Stock 688192 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Equities

688192

CNE1000055W8

Biotechnology & Medical Research

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
37.68 CNY +6.44% Intraday chart for Dizal (Jiangsu) Pharmaceutical Co., Ltd. -5.80% -21.25%
Apr. 07 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Dizal's Sunvozertinib for the First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations CI
Feb. 23 Dizal Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Dizal Jiangsu Pharmaceutical Co Ltd is a China-based company mainly engaged in the exploration, research, development and commercialization of innovative biomedicine. The Company focuses on diseases such as malignant tumors and immune diseases. The main candidate innovative drugs in the Company's research and development (R&D) pipeline are DZD4205, DZD9008, DZD1516, DZD2269, DZD8586, DZD0095. The Company is still in the R&D stage.

Number of employees: 424

Managers

Managers TitleAgeSince
Xiao Lin Zhang CEO
 Chief Executive Officer 60 17-10-26
Wei Wen Dong CHM
 Chairman 38 18-05-31
Hong Bin Lu DFI
 Director of Finance/CFO 46 20-06-30
Qing Bei Zeng CTO
 Chief Tech/Sci/R&D Officer 62 17-11-30
Zhen Fan Yang CTO
 Chief Tech/Sci/R&D Officer 56 17-11-30

Members of the board

Members of the board TitleAgeSince
Simon Lü BRD
 Director/Board Member 56 17-09-30
Xue Gong Wang BRD
 Director/Board Member 52 20-09-06
Guan Shan Zhu BRD
 Director/Board Member 60 20-09-07
Xin Zhang BRD
 Director/Board Member 52 20-09-07
Xiao Lin Zhang CEO
 Chief Executive Officer 60 17-10-26
Rodolphe Peter Andre Grepinet BRD
 Director/Board Member 51 17-09-30
Hong Bin Lu DFI
 Director of Finance/CFO 46 20-06-30
Bin Jiang BRD
 Director/Board Member 60 20-09-07
Wei Wen Dong CHM
 Chairman 38 18-05-31
Andre Grepinet Rodolphe Peter
- -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 415,653,120 76,821,862 ( 18.48 %) 0 18.48 %

Shareholders

NameEquities%Valuation
Hongshan
18.43 %
21,806,801 18.43 % 136 M ¥
LAV Management Co., Ltd.
11.91 %
14,098,432 11.91 % 88 M ¥
Wuxi Xintou Jinshi Venture Capital Management Co. Ltd.
10.08 %
11,930,232 10.08 % 74 M ¥
ELI LILLY AND COMPANY
6.832 %
8,084,411 6.832 % 50 M ¥
Penghua Fund Management Co., Ltd.
4.396 %
5,202,009 4.396 % 32 M ¥
GF Fund Management Co., Ltd.
3.257 %
3,854,123 3.257 % 24 M ¥
Shanghai Sixie Investment Management Co., Ltd.
1.825 %
2,160,000 1.825 % 13 M ¥
Trinity Innovation Fund
1.317 %
1,558,244 1.317 % 10 M ¥
Hwabao WP Fund Management Co., Ltd.
0.4334 %
512,907 0.4334 % 3 M ¥
Bosera Asset Management Co., Ltd.
0.3525 %
417,130 0.3525 % 3 M ¥
NameEquities%Valuation
ASTRAZENECA PLC
37.58 %
108,923,023 37.58 % 678 M ¥
SDIC Innovation Investment Management Co. Ltd.
37.58 %
108,923,023 37.58 % 678 M ¥
Wuxi Dunhe Business Consulting Co. Ltd.
19.82 %
57,451,788 19.82 % 358 M ¥
Dezent Partners Ltd.
1.783 %
5,167,283 1.783 % 32 M ¥

Company contact information

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Building 4 199, 245 Liangjing Road

201203, Shanghai

+

http://www.dizalpharma.com
address Dizal (Jiangsu) Pharmaceutical Co., Ltd.(688192)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
37.68 CNY
Average target price
52.16 CNY
Spread / Average Target
+38.42%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. Stock Dizal (Jiangsu) Pharmaceutical Co., Ltd.
-21.25% 2.16B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.49% 96.73B
ARGENX SE Stock argenx SE
-0.44% 21.31B
BIONTECH SE Stock BioNTech SE
-16.61% 21.21B
GENMAB A/S Stock Genmab A/S
-5.06% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.14% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-27.40% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+1.44% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+21.29% 10.98B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-21.79% 8.56B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 688192 Stock
  4. Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.